STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 25th, 2019 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of December 4, 2018, by and between VBI Vaccines Inc., a British Columbia corporation (the “Company”), and Brii Biosciences Limited, an exempted company organized under the laws of the Cayman Islands (“Investor”).
Addendum to the Rental Agreement dated 16 January 2017 and the Rental Extension Agreement for an Unprotected Rental Property dated 21 January 2018 Drawn and entered into on 15 January 2019VBI Vaccines Inc/Bc • February 25th, 2019 • Pharmaceutical preparations
Company FiledFebruary 25th, 2019 IndustryWhereas on November 5, 2013, Ayalot Investments (Ramat Vered) 1994 Ltd. and Sarda Ltd. (Hereinafter jointly: “The Original Landlord”) and the Company signed a primary rental agreement and its addendums with regards to the Rental Property (The Rental Agreement and its addendums will hereinafter be known as: “The Primary Rental Agreement”);
WAIVER AGREEMENTWaiver Agreement • February 25th, 2019 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionTHIS WAIVER AGREEMENT (this “Agreement”), dated as of February 14, 2019, is entered into by and among VARIATION BIOTECHNOLOGIES (US), INC., a Delaware corporation (the “Borrower”); the Guarantors identified under the caption “GUARANTORS” on the signature pages hereto, and Perceptive Credit Holdings, LP, a Delaware limited partnership (the “Lender”). Terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement defined below.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • February 25th, 2019 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionThis COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is entered into as of December 4, 2018 (the “Effective Date”) between VBI VACCINES INC., a company organized under the laws of the Province of British Columbia, Canada (“VBI”), and having a principal place of business at 310 Hunt Club Road, Suite 201, Ottawa ON K1V 1C1, and Brii Biosciences Limited, an exempted company organized under the laws of the Cayman Islands (“Brii Bio”), having its registered office at Vistra (Cayman) Limited, PO Box 3119, Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman KYI-1205.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 25th, 2019 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionThis Amendment to Consulting Agreement (the “Amendment”), effective as of January 1st, 2019 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.